Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Sex Linked Disorders01:43

Sex Linked Disorders

Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Nursing Assessment of the Genitourinary System I: Health History01:21

Nursing Assessment of the Genitourinary System I: Health History

The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
Psychosexual Stages of Personality: Genital01:23

Psychosexual Stages of Personality: Genital

The genital stage is the final phase of Sigmund Freud's theory of psychosexual development, beginning at puberty, around age 12. During this stage, sexual energy shifts from self-focused interests to external individuals, marking the development of mature adult sexuality. Freud saw this phase as a time of sexual reawakening, with desires directed toward others outside the family. A healthy transition into this stage, according to Freud, signifies the emergence of two key aspects of adult...
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Active surveillance of low-grade prostate cancer using the SurACaP Criteria: A multi-institutional series with a median follow-up of 10years.

The French journal of urology·2024
Same author

Active surveillance in favorable intermediate-risk prostate cancer: A single-center experience.

The French journal of urology·2023
Same author

[Bladder augmentation in the era of botulinum toxin: Indications and results].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

[Which non pharmacological interventions should be offered to patients treated with androgen deprivation therapy for prostate cancer? A systematic review].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

Saline bladder infusion vs standard catheter removal in patients with acute urinary retention related to benign prostatic hyperplasia: The BLAPERF Study.

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2023
Same author

[Evaluation of the results and feasibility of vibration, diuresis and inversion therapy in the treatment of upper urinary tract stones].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022

Related Experiment Video

Updated: May 10, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

[Sexuality and prostate cancer].

S Droupy1, B Al Said, E Lechevallier

  • 1Service d'urologie andrologie, CHU de Nîmes, place du Professeur-Robert-Debré, 30029 Nîmes cedex 09, France. stephane.droupy@chu-nimes.fr

Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|July 9, 2013
PubMed
Summary

Prostate cancer treatments negatively impact sexual function. Recent advancements focus on managing sexual dysfunction, with robotic surgery and pharmacological erectile rehabilitation showing promise for improved recovery and maintaining intimacy.

Keywords:
CancerCoupleProstateProstate cancerProstatectomie totaleRadical prostatectomyRehabilitationRééducationSexualitySexualité

More Related Videos

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Related Experiment Videos

Last Updated: May 10, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

Area of Science:

  • Urology
  • Oncology
  • Sexual Medicine

Context:

  • Prostate cancer treatments significantly affect patients' sexual health and quality of life.
  • Maintaining sexual function is a primary concern for men undergoing prostate cancer therapy.

Purpose:

  • To review recent developments in managing sexual dysfunction following prostate cancer treatment.
  • To inform healthcare providers and patients about current therapeutic options and their outcomes.

Summary:

  • Robotic radical prostatectomy may lead to faster erectile function recovery than traditional laparoscopy.
  • Pharmacological erectile rehabilitation, including intracavernous injections and phosphodiesterase type 5 inhibitors (PDE5i), can aid recovery.
  • Assessing couple sexuality pre-treatment and exploring non-erectile sexual function (e.g., orgasm) are crucial for preserving intimacy.

Impact:

  • Provides insights into optimizing sexual recovery after prostate cancer treatment.
  • Highlights the importance of a holistic approach, considering both physical and psychological aspects of sexual health.
  • Emphasizes the role of early intervention and tailored therapeutic strategies for improved patient outcomes.